Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Karl Nicholson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Living Beings
Geographic Areas
Procedures
Phenomena
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
18
Wiselka, Martin
11
Stephenson, Iain
9
Zambon, Maria
5
Nguyen-Van-Tam, Jonathan
5
Podda, Audino
4
Wood, John
4
Wailoo, Allan
4
Zambon, Maria
3
Sutton, Alex
3
Abrams, Keith
3
Ahmed, AH
3
Colegate, Anthony
3
Hammersley, VS
3
Kent, J
2
McNally, Teresa
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Karl Nicholson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Nicholson Karl G
Influenza and vaccine development: a continued battle.
Expert review of vaccines 2009;8(4):373-4.
-
2009: Tappenden P; Jackson R; Cooper K; Rees A; Simpson E; Read R; Nicholson K
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2009;13(11):iii, ix-xii, 1-246.
-
2008: Wailoo Allan J; Sutton Alexander J; Cooper Nicola J; Turner David A; Abrams Keith R; Brennan Alan; Nicholson Karl G
Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(2):160-71.
-
2006: Stephenson Iain; Zambon Maria C; Rudin Anna; Colegate Anthony; Podda Audino; Bugarini Roberto; Del Giudice Giusseppe; Minutello Ada; Bonnington Susan; Holmgren Jan; Mills Kingston H G; Nicholson Karl G
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Journal of virology 2006;80(10):4962-70.
-
2006: Turner D A; Wailoo A J; Cooper N J; Sutton A J; Abrams K R; Nicholson K G
The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.
Vaccine 2006;24(7):1035-43.
-
2006: Nicholson Karl G; McNally Teresa; Silverman Michael; Simons Paul; Stockton Joanne D; Zambon Maria C
Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children.
Vaccine 2006;24(1):102-8.
-
2005: Stephenson Iain; Bugarini Roberto; Nicholson Karl G; Podda Audino; Wood John M; Zambon Maria C; Katz Jacqueline M
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
The Journal of infectious diseases 2005;191(8):1210-5.
-
2004: Stephenson Iain; Nicholson Karl G; Wood John M; Zambon Maria C; Katz Jacqueline M
Confronting the avian influenza threat: vaccine development for a potential pandemic.
The Lancet infectious diseases 2004;4(8):499-509.
-
2004: Stephenson I; Wood J M; Nicholson K G; Charlett A; Zambon M C
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine.
Virus research 2004;103(1-2):91-5.
-
2003: Stephenson Iain; Nicholson Karl G; Glück Reinhardt; Mischler Robert; Newman Robert W; Palache Abraham M; Verlander Neville Q; Warburton Fiona; Wood John M; Zambon Maria C
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.
Lancet 2003;362(9400):1959-66.
-
2003: Nicholson Karl G; Wood John M; Zambon Maria
Influenza.
Lancet 2003;362(9397):1733-45.
-
2003: Nicholson Karl G; McNally Teresa; Silverman Michael; Simons Paul; Zambon Maria C
Influenza-related hospitalizations among young children in Leicestershire.
The Pediatric infectious disease journal 2003;22(10 Suppl):S228-30.
-
2003: Stephenson I; Wood J M; Nicholson K G; Zambon M C
Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.
Journal of medical virology 2003;70(3):391-8.
-
2003: Cooper Nicola J; Sutton Alexander J; Abrams Keith R; Wailoo Allan; Turner David; Nicholson Karl G
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
BMJ (Clinical research ed.) 2003;326(7401):1235.
-
2003: Stephenson Iain; Roper John; Fraser Maria; Nicholson Karl; Wiselka Martin
Dengue fever in febrile returning travellers to a UK regional infectious diseases unit.
Travel medicine and infectious disease 2003;1(2):89-93.
-
2003: Stephenson Iain; Nicholson Karl G; Colegate Anthony; Podda Audino; Wood John; Ypma Ellen; Zambon Maria
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population.
Vaccine 2003;21(15):1687-93.
-
2003: Zambon Maria; Nicholson Karl G
Sudden acute respiratory syndrome.
BMJ (Clinical research ed.) 2003;326(7391):669-70.
-
2003: Turner D; Wailoo A; Nicholson K; Cooper N; Sutton A; Abrams K
Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
Health technology assessment (Winchester, England) 2003;7(35):iii-iv, xi-xiii, 1-170.
-
2002: Wood J M; Nicholson K G; Stephenson I; Zambon M; Newman R W; Major D L; Podda A
Experience with the clinical development of influenza vaccines for potential pandemics.
Medical microbiology and immunology 2002;191(3-4):197-201.
-
2001: Nicholson K G; Colegate A E; Podda A; Stephenson I; Wood J; Ypma E; Zambon M C
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
Lancet 2001;357(9272):1937-43.
-
2000: Nicholson K G
Should staff in long-stay hospitals for elderly patients be vaccinated against influenza?
Lancet 2000;355(9198):83-4.
-
1999: Wiselka M J; Nicholson K G; Rowley S; Bibby K
Cytomegalovirus viraemia has poor predictive value for the development of cytomegalovirus disease in patients with advanced HIV-infection.
The Journal of infection 1999;39(3):187-92.
-
1999: Nicholson K G; Kent J; Hammersley V
Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination.
Epidemiology and infection 1999;123(1):103-8.
-
1999: Stephenson I; Nicholson K G
Chemotherapeutic control of influenza.
The Journal of antimicrobial chemotherapy 1999;44(1):6-10.
-
1998: Shirtcliffe P; Cameron E; Nicholson K G; Wiselka M J
Don't forget dengue! Clinical features of dengue fever in returning travellers.
Journal of the Royal College of Physicians of London 1998;32(3):235-7.
-
1998: Nicholson K G; Nguyen-Van-Tam J S; Ahmed A H; Wiselka M J; Leese J; Ayres J; Campbell J H; Ebden P; Eiser N M; Hutchcroft B J; Pearson J C; Willey R F; Wolstenholme R J; Woodhead M A
Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.
Lancet 1998;351(9099):326-31.
-
1997: Colquhoun A J; Nicholson K G; Botha J L; Raymond N T
Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes.
Epidemiology and infection 1997;119(3):335-41.
-
1997: Nicholson K G; Kent J; Hammersley V; Cancio E
Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden.
BMJ (Clinical research ed.) 1997;315(7115):1060-4.
-
1997: Wiselka M J; Nicholson K G
Outpatient parenteral antimicrobial therapy: experience in a large teaching hospital.
The Journal of infection 1997;35(1):73-6.
-
1997: Ahmed A H; Nicholson K G; Hammersley V S; Kent J
Influenza vaccination in patients with asthma: effect on peak expiratory flow, asthma symptoms and use of medication.
Vaccine 1997;15(9):1008-9.
-
1997: Ahmed A H; Nicholson K G; Nguyen-van Tam J S; Pearson J C
Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic.
Epidemiology and infection 1997;118(1):27-33.
-
1996: Collinson J; Nicholson K G; Cancio E; Ashman J; Ireland D C; Hammersley V; Kent J; O'Callaghan C
Effects of upper respiratory tract infections in patients with cystic fibrosis.
Thorax 1996;51(11):1115-22.
-
1996: Nicholson K G; Kent J; Hammersley V; Cancio E
Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study.
BMJ (Clinical research ed.) 1996;313(7065):1119-23.
-
1996: Ahmed A H; Nicholson K G
Delays and diversity in the practice of local research ethics committees.
Journal of medical ethics 1996;22(5):263-6.
-
1996: Nicholson K G
Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.
Epidemiology and infection 1996;116(1):51-63.
-
1996: Nicholson K G
Use of antivirals in influenza in the elderly: prophylaxis and therapy.
Gerontology 1996;42(5):280-9.
-
1995: Ahmed A E; Nicholson K G; Nguyen-Van-Tam J S
Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.
Lancet 1995;346(8975):591-5.
-
1994: Claydon A H; Nicholson K G; Wiselka M J; Firmin R K
Varicella pneumonitis: a role for extra-corporeal membrane oxygenation?
The Journal of infection 1994;28(1):65-7.
-
1993: Nicholson K G; Ahmed A H
Rapid immune response to influenza vaccination.
Lancet 1993;342(8885):1494-5.
-
1993: Nguyen-Van-Tam J S; Nicholson K G
Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season.
Epidemiology and infection 1993;111(2):347-55.
-
1993: Wiselka M J; Kent J; Cookson J B; Nicholson K G
Impact of respiratory virus infection in patients with chronic chest disease.
Epidemiology and infection 1993;111(2):337-46.
-
1993: Nicholson K G; Kent J; Ireland D C
Respiratory viruses and exacerbations of asthma in adults.
BMJ (Clinical research ed.) 1993;307(6910):982-6.
-
1993: Ireland D C; Kent J; Nicholson K G
Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR.
Journal of medical virology 1993;40(2):96-101.
-
1993: Wiselka M J; Nicholson K G
Schistosomiasis in Leicester.
The Journal of infection 1993;26(2):177-9.
-
1992: Nguyen-van-Tam J S; Nicholson K G
Influenza deaths in Leicestershire during the 1989-90 epidemic: implications for prevention.
Epidemiology and infection 1992;108(3):537-45.
-
1992: Nicholson K G; Baker D J; Chakraverty P; Farquhar A; Hurd D; Kent J; Litton P A; Smith S H
Immunogenicity of inactivated influenza vaccine in residential homes for elderly people.
Age and ageing 1992;21(3):182-8.
-
1992: Nicholson K G
Clinical features of influenza.
Seminars in respiratory infections 1992;7(1):26-37.
-
1992: Wiselka M J; Kent J; Nicholson K G; Stern M
Influenza and asthma.
Lancet 1992;339(8789):367-8.
-
1991: Wiselka M J; Nicholson K G; Kent J; Cookson J B; Tyrrell D A
Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease.
Thorax 1991;46(10):706-11.
-
1991: Nicholson K G; Wiselka M J
Amantadine for influenza A.
BMJ (Clinical research ed.) 1991;302(6774):425-6.
-
1990: Nicholson K G; Baker D J; Farquhar A; Hurd D; Kent J; Smith S H
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.
Epidemiology and infection 1990;105(3):609-18.
-
1990: Wiselka M J; Kent J; Nicholson K G
Malaria in Leicester 1983-1988: a review of 114 cases.
The Journal of infection 1990;20(2):103-10.
-
1989: Kurinczuk J J; Nicholson K G
Uptake of influenza vaccination by patients with serious cardiac disease.
BMJ (Clinical research ed.) 1989;299(6695):367.
-
1989: Nicholson K G; Wiselka M J
Infectious diseases. A review.
Journal of the Royal College of Physicians of London 1989;23(3):147-51.
-
1989: Coole L; Wiselka M J; Nicholson K G
Malaria prophylaxis in travellers from Britain.
The Journal of infection 1989;18(3):209-12.
-
1988: Ward S C; Wiselka M J; Nicholson K G
Still's disease and myocarditis associated with recent mumps infection.
Postgraduate medical journal 1988;64(755):693-5.
-
1988: Steare S E; Wiselka M J; Kurinczuk J J; Nicholson K G
Mycoplasma pneumoniae infection associated with Henoch-Schonlein purpura.
The Journal of infection 1988;16(3):305-7.
-
1987: Nicholson K G; Wiselka M J; May A
Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985-86 immunization programme in Trent, UK.
Vaccine 1987;5(4):302-6.
-
1987: Nicholson K G; Farrow P R; Bijok U; Barth R
Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man.
Vaccine 1987;5(3):208-10.
-
1987: Wiselka M J; Nicholson K G; Ward S C; Flower A J
Acute infection with human immunodeficiency virus associated with facial nerve palsy and neuralgia.
The Journal of infection 1987;15(2):189-90.
-
1984: Farrow P R; Nicholson K G
Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin.
The Journal of infection 1984;9(2):157-60.
Sign-in to see more
